These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1942629)

  • 1. [Iatrogenic diseases in the elderly].
    Kuzuhara S
    Nihon Ronen Igakkai Zasshi; 1991 Jul; 28(4):493-8. PubMed ID: 1942629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic acidosis and hypoglycemia during calcium hopantenate administration--report on 5 patients].
    Ohsuga S; Ohsuga H; Takeoka T; Ikeda A; Shinohara Y
    Rinsho Shinkeigaku; 1989 Jun; 29(6):741-6. PubMed ID: 2582687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Consciousness disorders in the aged due to therapeutic drugs].
    Watanabe R
    Nihon Naika Gakkai Zasshi; 1990 Apr; 79(4):475-9. PubMed ID: 2373929
    [No Abstract]   [Full Text] [Related]  

  • 4. Reye-like syndrome following treatment with the pantothenic acid antagonist, calcium hopantenate.
    Noda S; Umezaki H; Yamamoto K; Araki T; Murakami T; Ishii N
    J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):582-5. PubMed ID: 3379435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Delayed type malignant syndrome and Parkinson's syndrome due to tiapride, Reye-like syndrome induced by calcium hopantenate].
    Noda S
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):538-41. PubMed ID: 10434717
    [No Abstract]   [Full Text] [Related]  

  • 6. Lactic acidosis with hypoglycemia and hyperammonemia observed in two uremic patients during calcium hopantenate treatment.
    Otsuka M; Akiba T; Okita Y; Tomita K; Yoshiyama N; Sasaoka T; Kanayama M; Marumo F
    Jpn J Med; 1990; 29(3):324-8. PubMed ID: 2273615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary organic acids in elderly Japanese patients with ketosis and encephalopathy who have taken panto-yl-gamma-aminobutyrate, calcium salt (calcium hopantenate, HOPA).
    Nakanishi T; Funahashi S; Shimizu A; Hayashi A
    Clin Chim Acta; 1990 Apr; 188(1):85-90. PubMed ID: 2347085
    [No Abstract]   [Full Text] [Related]  

  • 8. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
    Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute encephalopathy with hyperammonemia and dicarboxylic aciduria during calcium hopantenate therapy: a patient report.
    Kimura A; Yoshida I; Ono E; Matsuishi T; Yoshino M; Yamashita F; Yamamoto M; Hashimoto T; Shinka T; Kuhara T
    Brain Dev; 1986; 8(6):601-5. PubMed ID: 3826551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iatrogenic neurological disorders in old people: a review].
    Kuzuhara S
    Nihon Ronen Igakkai Zasshi; 2005 Jan; 42(1):21-4. PubMed ID: 15732350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3 cases of acute encephalopathy associated with calcium hopantenate administration].
    Sugimoto T; Yasuhara A; Nishida N; Sakane Y; Sugimoto Y
    No To Hattatsu; 1983; 15(3):258-9. PubMed ID: 6882599
    [No Abstract]   [Full Text] [Related]  

  • 12. [The relationship between the physical features and medications in Reye-like syndrome in elderly patients].
    Itagaki T; Hishimura M; Hatta M; Takenaka H; Yoshida R; Yasuhara O; Urushibara A
    Nihon Ronen Igakkai Zasshi; 1989 Nov; 26(6):608-16. PubMed ID: 2634128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parkinsonism, depression and akathisia induced by flunarizine, a calcium entry blockade--report of 31 cases].
    Kuzuhara S; Kohara N; Ohkawa Y; Fuse S; Yamanouchi H
    Rinsho Shinkeigaku; 1989 Jun; 29(6):681-6. PubMed ID: 2582681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of Reye's syndrome occurred during administration of calcium hopantenate].
    Shimizu S; Miura M; Kawaguchi T; Nakamura Y; Takei M; Miyahara H; Furuta K; Sodeyama T; Kiyosawa K; Furuta S
    Nihon Shokakibyo Gakkai Zasshi; 1990 Nov; 87(11):2540-4. PubMed ID: 2277444
    [No Abstract]   [Full Text] [Related]  

  • 15. [A clinico-biochemical study of acute encephalopathy in patients treated with Ca-hopantenate].
    Izumi T; Utsumi H; Osawa M; Fukuyama Y
    No To Hattatsu; 1985 Sep; 17(5):426-30. PubMed ID: 3935144
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal fatty acid metabolism in patients in hopantenate therapy during clinical episodes.
    Matsumoto M; Kuhara T; Inoue Y; Shinka T; Matsumoto I
    J Chromatogr; 1991 Jan; 562(1-2):139-45. PubMed ID: 2026687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute encephalopathy with hepatic steatosis induced by pantothenic acid antagonist, calcium hopantenate, in dogs.
    Noda S; Haratake J; Sasaki A; Ishii N; Umezaki H; Horie A
    Liver; 1991 Jun; 11(3):134-42. PubMed ID: 1886458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
    Teive HA; Troiano AR; Germiniani FM; Werneck LC
    Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.